{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:29:20Z","timestamp":1782926960130,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,9]]},"DOI":"10.7759\/cureus.59948","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T09:16:45Z","timestamp":1715246205000},"source":"Crossref","is-referenced-by-count":1,"title":["Safety of Extended Propofol Infusions in Critically Ill Pediatric Patients"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Moas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elber Y","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Irazuzta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Filipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourtney K","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalen","family":"Manasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/52.8.731","article-title":"Animal studies of the anaesthetic activity of ICI 35 868","volume":"52","author":"Glen JB","year":"1980","unstructured":"Glen JB. Animal studies of the anaesthetic activity of ICI 35 868. Br J Anaesth. 1980, 52:731-42. 10.1093\/bja\/52.8.731","journal-title":"Br J Anaesth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic MM","year":"2018","unstructured":"Sahinovic MM, Struys MM, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018, 57:1539-58. 10.1007\/s40262-018-0672-3","journal-title":"Clin Pharmacokinet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6854.613","article-title":"Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports","volume":"305","author":"Parke TJ","year":"1992","unstructured":"Parke TJ, Stevens JE, Rice AS, et al.. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992, 305:613. 10.1136\/bmj.305.6854.613","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.1998.00282.x","article-title":"Propofol infusion syndrome in children","volume":"8","author":"Bray RJ","year":"1998","unstructured":"Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998, 8:491-9. 10.1046\/j.1460-9592.1998.00282.x","journal-title":"Paediatr Anaesth"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/79.3.276","article-title":"Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care","volume":"79","author":"Martin PH","year":"1997","unstructured":"Martin PH, Murthy BV, Petros AJ. Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care. Br J Anaesth. 1997, 79:276-9.","journal-title":"Br J Anaesth"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000484","article-title":"Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q","volume":"122","author":"Vanlander AV","year":"2015","unstructured":"Vanlander AV, Okun JG, de Jaeger A, et al.. Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q. Anesthesiology. 2015, 122:343-52. 10.1097\/ALN.0000000000000484","journal-title":"Anesthesiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2011.02628.x","article-title":"Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome","volume":"56","author":"Vanlander AV","year":"2012","unstructured":"Vanlander AV, Jorens PG, Smet J, et al.. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand. 2012, 56:520-5. 10.1111\/j.1399-6576.2011.02628.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2004.01299.x","article-title":"A case of propofol toxicity: further evidence for a causal mechanism","volume":"14","author":"Withington DE","year":"2004","unstructured":"Withington DE, Decell MK, Al Ayed T. A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth. 2004, 14:505-8. 10.1111\/j.1460-9592.2004.01299.x","journal-title":"Paediatr Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-11.1.17","article-title":"Propofol-related infusion syndrome in critically ill pediatric patients: coincidence, association, or causation?","volume":"11","author":"Timpe EM","year":"2006","unstructured":"Timpe EM, Eichner SF, Phelps SJ. Propofol-related infusion syndrome in critically ill pediatric patients: coincidence, association, or causation?. J Pediatr Pharmacol Ther. 2006, 11:17-42. 10.5863\/1551-6776-11.1.17","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.6.1177","article-title":"Continuous propofol infusion in 142 critically ill children","volume":"110","author":"Cornfield DN","year":"2002","unstructured":"Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics. 2002, 110:1177-81. 10.1542\/peds.110.6.1177","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2021.1937009","article-title":"Propofol 2%: understanding a new concentration of a well-known medication","volume":"34","author":"Regier BA","year":"2021","unstructured":"Regier BA, Meyer TA, McAllister RK. Propofol 2%: understanding a new concentration of a well-known medication. Proc (Bayl Univ Med Cent). 2021, 34:642-3. 10.1080\/08998280.2021.1937009","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000021","article-title":"Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*","volume":"15","author":"Koriyama H","year":"2014","unstructured":"Koriyama H, Duff JP, Guerra GG, Chan AW. Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*. Pediatr Crit Care Med. 2014, 15:e66-71. 10.1097\/PCC.0000000000000021","journal-title":"Pediatr Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3182388a95","article-title":"Use of propofol in pediatric intensive care units: a national survey in Germany","volume":"13","author":"Kruessell MA","year":"2012","unstructured":"Kruessell MA, Udink ten Cate FE, Kraus AJ, Roth B, Trieschmann U. Use of propofol in pediatric intensive care units: a national survey in Germany. Pediatr Crit Care Med. 2012, 13:e150-4. 10.1097\/PCC.0b013e3182388a95","journal-title":"Pediatr Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0259-6","article-title":"Propofol: a review of its role in pediatric anesthesia and sedation","volume":"29","author":"Chidambaran V","year":"2015","unstructured":"Chidambaran V, Costandi A, D'Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015, 29:543-63. 10.1007\/s40263-015-0259-6","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2019.08.011","article-title":"Propofol use in newborns and children: is it safe? A systematic review","volume":"96","author":"Filho EM","year":"2020","unstructured":"Filho EM, Riechelmann MB. Propofol use in newborns and children: is it safe? A systematic review. J Pediatr (Rio J). 2020, 96:289-309. 10.1016\/j.jped.2019.08.011","journal-title":"J Pediatr (Rio J)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002873","article-title":"2022 Society of Critical Care Medicine Clinical Practice Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility","volume":"23","author":"Smith HA","year":"2022","unstructured":"Smith HA, Besunder JB, Betters KA, et al.. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility. Pediatr Crit Care Med. 2022, 23:e74-110. 10.1097\/PCC.0000000000002873","journal-title":"Pediatr Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3181956bda","article-title":"Monitoring biochemical parameters as an early sign of propofol infusion syndrome: false feeling of security","volume":"10","author":"Veldhoen ES","year":"2009","unstructured":"Veldhoen ES, Hartman BJ, van Gestel JP. Monitoring biochemical parameters as an early sign of propofol infusion syndrome: false feeling of security. Pediatr Crit Care Med. 2009, 10:e19-21. 10.1097\/PCC.0b013e3181956bda","journal-title":"Pediatr Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-5153.2012.00488.x","article-title":"The use of propofol sedation in a paediatric intensive care unit","volume":"17","author":"Svensson ML","year":"2012","unstructured":"Svensson ML, Lindberg L. The use of propofol sedation in a paediatric intensive care unit. Nurs Crit Care. 2012, 17:198-203. 10.1111\/j.1478-5153.2012.00488.x","journal-title":"Nurs Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27925","article-title":"Propofol in the pediatric intensive care unit, a safe and effective agent in reducing pain and sedation infusions: a single-center retrospective study","volume":"14","author":"Uppuluri S","year":"2022","unstructured":"Uppuluri S, Villarreal EG, Dorsey V, Yousaf F, Farias JS, Flores S, Loomba RS. Propofol in the pediatric intensive care unit, a safe and effective agent in reducing pain and sedation infusions: a single-center retrospective study. Cureus. 2022, 14:e27925. 10.7759\/cureus.27925","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/239197-safety-of-extended-propofol-infusions-in-critically-ill-pediatric-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T09:16:47Z","timestamp":1715246207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/239197-safety-of-extended-propofol-infusions-in-critically-ill-pediatric-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.59948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}